Stay up to date with free updates Simply sign in Pharmaceutical industry myFT Digest — delivered directly to your inbox. Alphaville has received a LOT of equity research regarding the effects of weight loss pills like Ozempic* and Wegovy (mainFT has a great overview here). As the efficacy of these treatments becomes clear, many analysts … Read more
Retail analysts say pharmaceutical advocates have hyped the success of high-priced weight-loss drugs like Ozempic in a campaign to make appetite suppressants a new standard in obesity care. enlarged. Walmart reported this month that it has seen a slight decrease in food purchases among customers using prescription anti-diabetic drugs such as Mounjaro, Ozempic and Wegovy. … Read more
The makers of Ozempic, Wegovy and Mounjaro are racing to prove that these hugely popular drugs offer health benefits beyond weight loss. and diabetes. They say doing so would make it easier for patients to get insurance to cover expensive drugs. Clinical trials are underway to see if the drug can reduce the risk of … Read more
Updated October 11, 2023, 03:29 pm EDT Top line A new survey shows more employers could cover popular diabetes and weight loss drugs like Ozempic and Wegovy by 2024, allowing workers to avoid out-of-pocket costs overpaying, a new survey finds, although the high cost of these drugs has caused other workplaces to stop covering them … Read more
While pharmacies dispensing the drug marks a victory for reproductive freedom, an impending Supreme Court case could cut off access to the drug in states where abortion remains legal. France. (AP Photo/Susan Walsh, File) A group of independent pharmacies in states across the country have begun distributing the abortion drug mifepristonean thanks to newly implemented … Read more
The makers of Ozempic, Wegovy and Mounjaro are racing to prove that these hugely popular drugs offer health benefits beyond weight loss and diabetes. They say doing so would make it easier for patients to get insurance to cover expensive drugs. Clinical trials are underway to see if the drug can reduce the risk of … Read more